Results 1 to 10 of about 7,539 (166)

Bidirectional Interaction Between Liposomal Amphotericin B Pharmacokinetics and Parasite Dynamics in Patients With Post-Kala-Azar Dermal Leishmaniasis: Potential Implications for Optimal Dosing. [PDF]

open access: yesClin Pharmacol Ther
Post‐kala‐azar dermal leishmaniasis (PKDL) involves a high macrophage burden in which the Leishmania parasites reside. Liposomal amphotericin B (LAmB) plays a key role in the treatment of PKDL. The mononuclear phagocyte system (MPS) is crucial in the distribution of liposomal drugs as well as the leishmaniasis pathophysiology.
Chu WY   +12 more
europepmc   +2 more sources

Visceral leishmaniasis (kala-azar) caused by L. mexicana in a patient with AIDS. [PDF]

open access: yesProc (Bayl Univ Med Cent), 2023
Mitchell KL   +5 more
europepmc   +1 more source

Can cutaneous leishmaniasis provoke a resurgence of kala-azar in the Indian subcontinent? [PDF]

open access: yesBMC Infect Dis
Bhattarai NR   +12 more
europepmc   +1 more source

Revisiting the diagnosis and treatment of Para Kala-azar Dermal Leishmaniasis in the endemic foci of Bangladesh. [PDF]

open access: yesPLoS One, 2023
Maruf S   +9 more
europepmc   +1 more source

Immune-Pathological Correlates of Disease Severity in New-World Kala-Azar: The Role of Parasite Load and Cytokine Profiles. [PDF]

open access: yesPathogens
Sene IS   +7 more
europepmc   +1 more source

Post-Kala-Azar Dermal Leishmaniasis. [PDF]

open access: yesAm J Trop Med Hyg
Sharma A, Bishnoi A, Parsad D.
europepmc   +1 more source

Home - About - Disclaimer - Privacy